FDA: Most Sponsors Fulfilling Postmarket Requirements

Clinical Trials Advisor
A A
As of the end of fiscal 2015, postmarket requirements were fulfilled for 69 percent of NDAs, marking a slight decline from the previous fiscal year.

To View This Article:

Login

Subscribe To Clinical Trials Advisor